Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 6INDUSTRY 4OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1001Lymphoid 35Tumor-Agnostic 26Thoracic 23Gynecologic 23Other solid neoplasm 19Breast 17Genitourinary 16Head & Neck 9Other hematologic neoplasm 7Dermatologic 6CNS 4Plasma cell 2NET 2Myeloid 2Endocrine 2Sarcoma 1Other neoplasm 1Other 1Classical hematology 1

Conditions

Osteosarcoma 1Neuroblastoma 1Medulloblastoma 1Central Nervous System Neoplasms 1

Interventions

Radiotherapy 136Cyclophosphamide 132Temozolomide 116Doxorubicin 99Filgrastim 68Ifosfamide 64Gemcitabine 58Etoposide 55Bevacizumab 51Imatinib Mesylate 50fludarabine phosphate 49Irinotecan 46pembrolizumab 45Peripheral Blood Stem Cell Transplantation 45pazopanib 43Magnetic Resonance Spectroscopy 41Methotrexate 40Carboplatin 40Busulfan 40Vincristine 38Nivolumab 37Melphalan 37Surgical Procedures, Operative 36Cisplatin 36Radiation 33Blood Specimen Collection 33Mycophenolic Acid 31Cyclosporine 31Docetaxel 29Trabectedin 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Oxaliplatin × Sarcoma × Clear all
NCT00407433 2009-08-07

Clinical Studies of Gemcitabine-Oxaliplatin

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Completed
156 enrolled
CNSSarcoma

Medulloblastoma, Neuroblastoma, Osteosarcoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡